Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
6 1 Where can I find more information? Treatment of castration-resistant prostate cancer Canadian Urological Association – Patient information www.cua.org Prostate Cancer Canada – Androgen deprivation therapy and medicines used www.prostatecancer.ca/Prostate-Cancer/ Treatment/ Canadian Cancer Society – Treatment of CRPC www.cancer.ca/en/cancer-information/ cancer-type/prostate/prostate-cancer/ A number of treatment options are available for castration-resistant prostate cancer (CRPC) that has spread beyond the prostate gland to other parts of the body (metastasized). The goals of treating metastatic CRPC are to control the disease, improve symptoms, and help patients live longer. What is castration-resistant prostate cancer? 2 How is CRPC treated? In some men taking hormone therapy for prostate cancer, their PSA (prostate-specific antigen) level may rise and keep rising after repeating the PSA test. Unfortunately, some prostate cancer cells can change over time and become resistant to hormone therapy. Your doctor will consider a number of factors when recommending a treatment for you. The following questions will help guide the choice. When this happens, the current treatment can no longer control the growth of the prostate cancer by itself. The cancer is then described as castration-resistant prostate cancer (CRPC). In the past this was called hormone-refractory prostate cancer. • Do you have symptoms from the prostate cancer and are they mild or severe? • Has the prostate cancer spread to other parts of the body? (Cancer that has spread is described as metastatic.) • Do you have other health conditions thatmake some therapies better choices than others? • What treatments for prostate cancer have you received so far? As a first step, your doctor may try changing your hormone therapy. In recent years, a number of new treatments have become available for men with metastatic CRPC. For men with CRPC that has not spread beyond the prostate (nonmetastatic), there is no standard treatment at this time. Ask your doctor about the possibility of entering clinical trials that can give access to new treatment options, and help find better ways to treat this stage of the disease. The development and production of this material was made possible through an educational grant provided by Amgen Canada Inc. and Astellas Pharma Canada, Inc. © 2014 Canadian Urological Association. All Rights Reserved. cua.org CRPC-10-14 The information in the publication is not intended to convey medical advice or to substitute for direct consultation with a qualified medical practitioner. The Canadian Urological Association disclaims all liability and legal responsibility howsoever caused, including negligence, for the information contained in or referenced by this brochure. cua.org 3 What are the treatment options for metastatic CRPC? A. Abiraterone Description B. Enzalutamide C. Radium-223 continued Description Important notes • Enzalutamide capsules are taken by mouth once a day • This therapy blocks androgens from signalling cancer cells to grow • Follow good personal cleanliness and hand- washing practices while receiving treatment and for at least 1 week after the last injection – this minimizes the potential for radiation exposure by household members and caregivers • Your healthcare team will give you advice on flushing the toilet and handling any clothes soiled with body fluids, urine, stool, or vomit • Make sure you keep your appointments for blood tests • Let your doctor know if you have a fever, chills, or any signs of infection • Abiraterone tablets are taken by mouth once a day • This drug prevents the production of androgens (the male sex hormones that can cause prostate cancer cells to grow) • Prednisone tablets must also be taken to reduce side effects from abiraterone Possible side effects Possible side effects • Enzalutamide is not suitable for men who have had a seizure or have risk factors for seizures • Blood pressure should be checked regularly • Carry a list of all your medicines so your pharmacist can check for drug interactions • Swelling of the feet or legs • Low potassium in the blood which may cause muscle weakness, muscle twitches, or a pounding heart beat • Loss of energy (fatigue) • Joint and muscle pain • Hot flashes • Diarrhea or constipation • Increase in blood pressure • Cough Important notes • Abiraterone should be taken on an empty stomach (1 hour before eating, or 2 hours after eating) • Prednisone should be taken with food • Prednisone is important to reduce side effects of abiraterone, such as swelling of the feet and legs, low potassium level in the blood, and increased blood pressure • You will need to have regular blood tests • Carry a list of all your medicines so your pharmacist can check for drug interactions NOTE: Some men may receive more than one of the treatment options discussed in this pamphlet. The best sequence of treatments is still being studied. The ability for doctors and their patients to gain access to these treatment options can vary from region to region. Your treating physician can give you further advice. • Loss of energy (fatigue) • Hot flashes • Headache • High blood pressure Important notes C. Radium-223 Description • A radioactive medicine is injected into the blood (intravenous, IV) every 4 weeks for a total of 6 treatments • Radium-223 goes to where the cancer has spread in the bone; it gives off radiation in the areas where the cancer is causing damage • Radium-223 therapy can improve patient survival and can also delay and reduce the risk of fractures and severe bone pain • Currently, Radium-223 is not widely available in Canada; it may be available to men who join a clinical trial D. Chemotherapy Examples: Docetaxel and cabazitaxel Description • These chemotherapy drugs are given by injection every 3 weeks • Chemotherapy drugs kill fast growing cells, including cancer cells • Prednisone tablets are taken by mouth each day as part of the chemotherapy regimen Possible side effects • Increase in risk for infections and fever • Shortness of breath and fatigue • More bruising or bleeding than usual • Nausea, vomiting, diarrhea • Loss of energy (fatigue), weakness • Mouth sores • Hair loss, fingernail changes Possible side effects Important notes • More bruising or bleeding than usual • Diarrhea • Nausea and vomiting • Increase in risk for infections • Pain, redness, or swelling at the injection site • Docetaxel is the first chemotherapy drug that is tried for metastatic CRPC • Cabazitaxel is considered later, after docetaxel has been tried and no longer works • Your healthcare team will provide you with information and also with support medicines to prevent and lessen the side effects from chemotherapy 4 What is the role of radiation therapy? External Beam Radiation Therapy (EBRT) or Stereotactic (or pinpoint) Body Radiation Therapy (SBRT) may be suggested for some men with CRPC. These types of radiation therapy can be used to relieve pain, improve mobility, stop bleeding, and prevent bone fractures and spinal cord problems. EBRT and SBRT are given using a machine to focus a radiation beam at a specific cancer site in the bones or other area of concern. (The role of Radium-223 is discussed in the previous section.) 5 How will I be monitored during treatment? Your doctor will meet with you regularly to monitor your treatment. During this time, your doctor will measure your PSA level and look at other blood test results. CAT (CT) scans and bone scans may also be needed. During your appointments, you and your doctor will discuss ways to manage the symptoms and side effects you may be experiencing.